Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimo Dietrich

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Expert Review of Respiratory Medicine|August 23, 2013
The role of DNA methylation as biomarkers in the clinical management of lung cancerMichael Fleischhacker, Dimo Dietrich, Volker Liebenberg, et al.
Clinical Epigenetics|March 4, 2016
Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascitesMaria Jung, Svenja Pützer, Heidrun Gevensleben, et al.
Critical Reviews in Clinical Laboratory Sciences|June 1, 2014
Nucleic acid-based biomarkers in body fluids of patients with urologic malignanciesBernhard Ralla, Carsten Stephan, Sebastian Meller, et al.
Plos One|February 13, 2015
Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patientsBernd Schmidt, Julia Beyer, Dimo Dietrich, et al.
Oncotarget|October 21, 2022
Nectin-4 is widely expressed in head and neck squamous cell carcinomaChristine Sanders, Jan-Frederic Lau, Dimo Dietrich, et al.
Human Molecular Genetics|September 13, 2013
Extensive transcriptional complexity during hypoxia-regulated expression of the myoglobin gene in cancerAnne Bicker, Dimo Dietrich, Eva Gleixner, et al.
Clinical Epigenetics|February 12, 2020
H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockadeFriederike Hoffmann, Dennis Niebel, Pia Aymans, et al.
Immunotherapy|July 21, 2020
<i>PD-1</i>, <i>CTLA4</i>, <i>PD-L1</i> and <i>PD-L2</i> DNA methylation in papillary thyroid carcinomaLuka de Vos, Jörn Dietrich, Sebastian Strieth, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 5, 2012
DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patientsDimo Dietrich, Oliver Hasinger, Volker Liebenberg, et al.
Plos One|June 16, 2017
Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinomaVerena Sailer, Heidrun Gevensleben, Joern Dietrich, et al.
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Expert Review of Respiratory Medicine|August 23, 2013
The role of DNA methylation as biomarkers in the clinical management of lung cancerMichael Fleischhacker, Dimo Dietrich, Volker Liebenberg, et al.
Clinical Epigenetics|March 4, 2016
Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascitesMaria Jung, Svenja Pützer, Heidrun Gevensleben, et al.
Critical Reviews in Clinical Laboratory Sciences|June 1, 2014
Nucleic acid-based biomarkers in body fluids of patients with urologic malignanciesBernhard Ralla, Carsten Stephan, Sebastian Meller, et al.
Plos One|February 13, 2015
Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patientsBernd Schmidt, Julia Beyer, Dimo Dietrich, et al.
Oncotarget|October 21, 2022
Nectin-4 is widely expressed in head and neck squamous cell carcinomaChristine Sanders, Jan-Frederic Lau, Dimo Dietrich, et al.
Human Molecular Genetics|September 13, 2013
Extensive transcriptional complexity during hypoxia-regulated expression of the myoglobin gene in cancerAnne Bicker, Dimo Dietrich, Eva Gleixner, et al.
Clinical Epigenetics|February 12, 2020
H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockadeFriederike Hoffmann, Dennis Niebel, Pia Aymans, et al.
Immunotherapy|July 21, 2020
<i>PD-1</i>, <i>CTLA4</i>, <i>PD-L1</i> and <i>PD-L2</i> DNA methylation in papillary thyroid carcinomaLuka de Vos, Jörn Dietrich, Sebastian Strieth, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 5, 2012
DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patientsDimo Dietrich, Oliver Hasinger, Volker Liebenberg, et al.
Plos One|June 16, 2017
Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinomaVerena Sailer, Heidrun Gevensleben, Joern Dietrich, et al.
Pageof 12